Reported 0 shares, down 361,905 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2021 | Reduced | 0 | -361,905 (-100.0%) | 0 | $0 | 2021-11-15 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
5 managers reported LEXARIA BIOSCIENCE CORP for Q3 2021.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| SABBY MANAGEMENT LLC | Reduced | 332,971 | -68,275 | 0.09% | $699,000 | 3 qtrs |
| BOOTHBAY FUND MANAGEMENT LLC | Unchanged | 78,950 | 0 | 0.01% | $494,000 | 3 qtrs |
| CVI Holdings LLC | Unchanged | 45,000 | 0 | < 0.01% | $95,000 | 3 qtrs |
| ARMISTICE CAPITAL LLC This report | Reduced | 0 | -361,905 | 0 | $0 | 3 qtrs |
| CONCOURSE FINANCIAL GROUP SECURITIES INC | Unchanged | 0 | 0 | 0 | $0 | 3 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2021
- Filed
- November 15, 2021
- Filing type
- 13F-HR
- Position type
- *W EXP 01/11/202
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.